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Abstract
Background: Laparoscopic liver surgery is becoming increasingly common. This cohort study was
designed to directly compare perioperative outcomes of the left lateral segmentectomy via
laparoscopic and open approach.
Methods: Between 2002 and 2006 43 left lateral segmentectomies were performed at King's
College Hospital. Those excluded from analysis included previous liver resections, polycystic liver
disease, liver cirrhosis and synchronous operations. Of 20 patients analysed, laparoscopic (n = 10)
were compared with open left lateral segmentectomy (n = 10). Both groups had similar patient
characteristics.
Results: Morbidity rates were similar with no wound or chest infection in either group. The
conversion rate was 10% (1/10). There was no difference in operating time between the groups
(median time 220 minutes versus 179 minutes, p = 0.315). Surgical margins for all lesions were
clear. Less postoperative opiate analgesics were required in the laparoscopic group (median 2 days
versus 5 days, p = 0.005). The median postoperative in-hospital stay was less in the laparoscopic
group (6 days vs 9 days, p = 0.005). There was no mortality.
Conclusion: Laparoscopic left lateral segmentectomy is safe and feasible. Laparoscopic patients
may benefit from requiring less postoperative opiate analgesia and a shorter post-operative in-
hospital stay.
Background
Laparoscopic liver surgery, first performed in 1992 [1], is
becoming the method of choice as surgical expertise in
advanced laparoscopic techniques has developed. Laparo-
scopic enthusiasts have shown that it is safe and feasible
to perform laparoscopic liver surgery [2-5]. Due to its ana-
tomical accessibility left lateral segmentectomy (LLS) has
been considered the training operation for all liver sur-
geons [6].
Proposed benefits of laparoscopic liver surgery include
reduced overall blood loss, shorter hospital stay and less
post-operative pain with a faster return to normal activity.
But there are concerns as reported complications have
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included compromised oncological integrity [7-11],
uncontrollable bleeding [10,12,13] and gas emboli [14-
17].
To date one study has compared laparoscopic left lateral
segmentectomy with an open approach using historical
case controls [18]. Findings confirmed that the laparo-
scopic approach was safe and feasible, yet had signifi-
cantly longer operating times and no difference in post-
operative in-patient stay. The aim of this study was to
undertake a contemporaneous comparison between
laparoscopic and open left lateral segmentectomies.
Methods
We undertook a retrospective cohort study of the left lat-
eral segmentectomies in our institution between July
2002 and October 2006 (n = 43). Cases were included on
an intention to treat basis however, in an attempt to
reduce bias, patients having previous liver resections (n =
2), synchronous operations (n = 14), polycystic liver dis-
ease (n = 3), liver cirrhosis (n = 3) and hand port assisted
procedure (n = 1) were excluded (see figure 1). This
resulted in 20 left lateral segmentectomies for compari-
son, 10 in the laparoscopic (LG) and 10 in the open group
(OG). Selection was based on referral to the individual
consultants with all laparoscopic operations performed
by a single surgeon (AGP) and open operations under the
care of two surgeons (NH, MR). Selection-bias was mini-
mised by the random referral policy to the individual sur-
geons over this time period. All cases were discussed at the
liver multi-disciplinary meeting pre-operatively. A
detailed review of the medical records was conducted.
Data collection included patient characteristics, site of
lesion, operative details, postoperative analgesic require-
ments, morbidity and mortality, postoperative in-hospital
stay, pathology of specimen, weight of resected specimen
and tumour clearance margins. Ethical approval was not
required.
All patients were operated on in the supine position under
general anaesthesia with endo-tracheal intubation. A
broad spectrum antibiotic (Tazocin, Wyeth Laboratories,
Attrition diagram Figure 1
Attrition diagram.BMC Surgery 2009, 9:14 http://www.biomedcentral.com/1471-2482/9/14
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Madison NJ) was given to all patients. Prophylaxis against
deep vein thrombosis was given in the form of low-molec-
ular weight heparin, thrombo-embolic deterrent stock-
ings and intra-operative intermittent pneumatic
compression boots. Staging laparoscopy with intra-opera-
tive ultrasound was performed to exclude peritoneal dis-
ease and to identify any additional tumours, as
appropriate.
Laparoscopic technique
With the surgeon standing to the right of the patient pneu-
moperitoneum was established after accessing the
abdominal cavity using an open Hasson technique.
The initial port location varied depending upon previous
surgery. Intra-abdominal pressure was kept at approxi-
mately 15 mmHg. Four additional ports were inserted
(figure 2). A 30° laparoscope was used. The falciform and
left triangular ligament was divided using a harmonic
scalpel (Ethicon, Endo-Surgery Inc. Cincinnati Ohio). The
falciform ligament was used to retract and manipulate the
left lobe of the liver.
The line of resection was marked using the diathermy
hook, 5 mm left of the falciform ligament and transected
using a harmonic scalpel. In the umbilical fissure to the
left of the falciform ligament the segment II/III pedicles
were stapled and divided using Endo-GIA, 30 mm vascu-
lar staples (US Surgical, Norwalk CT). Liver parenchyma
was transected using a harmonic scalpel +/- .Cavitron
Ultrasonic Surgical Aspirator (CUSA®, Valleylab, Boulder
CO). The left hepatic vein was approached intra-paren-
chymally and transected with Endo-GIA 30 mm vascular
staples. The final attachment to the left triangular liga-
ment close to the diaphragm was divided using hook dia-
thermy and the specimen freed. Specimens were removed
using a retrieval bag through a pfannenstiel or low mid-
line incision. Fibrin glue was applied to the surface of the
liver if required and a closed suction drain was placed near
the transected liver. The skin was closed after infiltration
of local anaesthetic (0.5% bupivacaine).
Open technique
The open left lateral segmentectomies were performed as
described by Bismuth [19].
A laparotomy was performed via a transverse subcostal
incision with a midline extension if required. The left lobe
of the liver was mobilised and the parenchyma was
transected using CUSA®  and argon beam coagulation.
With full mobilisation of the left lobe of the liver, the seg-
ment II/III pedicles were ligated and divided. The left
hepatic vein was clamped at the end of the parenchymal
transection and sutured with 5/0 prolene. Transection
occurred through the liver parenchyma using CUSA® and
argon. Haemostasis was assured with the use of fibrin
glue, and a drain was inserted.
Data Analysis
Statistical analysis was performed using Mann-Whitney U
test unless otherwise stated. P-values < 0.05 were consid-
ered to be statistically significant. All data is reported as
median (range).
Results
Of the 43 liver resections performed in our institution
between July 2002 and October 2006, 20 patients met the
inclusion criteria for this study with 10 laparoscopic and
10 open left lateral segmentectomies. Patients presented
with either solid lesions, symptomatic liver cysts or liver
abscesses, within segments II/III.
There were no differences in the patient characteristics
between the two groups (Table 1). Median patient age was
54 years (25 - 72). 50% of patients were men (n = 10). The
patients had similar American Society of Anaesthesiology
(ASA) grading (I:II:III); 1:5:4 in the laparoscopic group
and 2:6:2 in the open group. Indication for left lateral seg-
mentectomy was malignant lesions in 50% of cases (n =
10).
Two patients in each group (20%) developed early com-
plications (< 30 days postoperatively). Minor morbidity
in the laparoscopic group (LG) included one urinary tract
infection, and a haematemesis (possibly secondary to
Trocar placement for laparoscopic left lateral segmentec- tomy Figure 2
Trocar placement for laparoscopic left lateral seg-
mentectomy. For extraction a pfannenstiel incision is usu-
ally used.BMC Surgery 2009, 9:14 http://www.biomedcentral.com/1471-2482/9/14
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non-steroidal anti-inflammatory drugs) which settled
conservatively. In the open group (OG) one patient devel-
oped supraventricular tachycardia four days post-opera-
tively, exacerbated by low potassium levels, which
resolved spontaneously. The second patient developed
hypoxia due to atelectasis, pleural effusions and a superfi-
cial haematoma. Only one late complication occurred, a
small incisional hernia at the junction of the Mercedes
incision in the OG 17 months postoperatively. No statis-
tically significant difference in morbidity between the two
groups was found (p = 0.725). There was no surgical mor-
tality in either group.
In the laparoscopic group one conversion to open (10%)
was necessary and occurred early in the series. The LLS was
performed for a liver tumour that showed evidence of
recent bleeding on a computerised tomography (CT) scan.
Intra-operatively the tumour/haematoma from the left
lateral segment was found adherent to the greater curve of
the stomach, which required a wedge resection of the
stomach. In order to avoid narrowing of the oesophago-
gastric junction the procedure was completed via an open
approach.
Portal triad clamping was not used in the laparoscopic
approach. In the OG it was used intermittently in 50% (5/
10) of patients, consultant preference. The median cumu-
lative clamp time duration was 35 minutes (20-60). There
was no significant difference in post-operative AST
changes between the LG, OG (portal triad clamping) and
OG (no portal triad clamping), one-way ANOVA. Within
the LG one patient required an intra-operative blood
transfusion (3 units) whilst in the OG two patients, both
with liver abscesses, required a transfusion (1-2 units).
There was no statistical difference in intra-operative blood
transfusion requirement between the two groups (p =
0.782).
The median operating time for the LG was 220 minutes
(116-335 minutes) versus 179 minutes (118-229 min-
utes) for the OG. No statistically significant difference was
found between the two groups, p = 0.315 (see Table 2).
The laparoscopic operating time has reduced over the
Table 1: Patient Characteristics
Laparoscopic n = 10 Open n = 10
Median age in years (range) 55
(34 - 72)
56
(25 - 68)
Gender
Male 5 5
Female 5 5
ASA Grade (I:II:III) 1:5:4 2:6:2
Diagnosis
Malignant 6 4
Benign 4 6
Table 2: Intra- and post-operative outcomes
Laparoscopic
n = 10
Open
n = 10
p-value
Intra-operative
Operating time (mins) (range) 220
(116-335)
179
(118-229)
p = 0.315
Clamping time (mins) 0 35 (n = 5)
Blood Transfusion (%) 10 20 p = 0.782
Post-operative
In hospital stay (days) 6 9 p = 0.005
Epidural use 1 9 p = 0.003
Opiod use (days)
(range)
2
(1-5)
5
(2-14)
p = 0.005
Level II care stay (%) 80 100 p = 0.282
Weight of specimen (g)
(range)
243.5
(99-577)
439
(213-1480)
p = 0.023
Resection margin (mm)
(range)
15
(3-30)
14.5
(0->20)
p = 0.669BMC Surgery 2009, 9:14 http://www.biomedcentral.com/1471-2482/9/14
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study period with median operating time of 240 minutes
in 2002, reduced to 163 minutes in 2006.
The LG had less analgesic requirements than the OG. This
was exemplified by the statistically significant median
postoperative opiate use 2 days (1-5) in LG versus 5 days
(2-14) in the OG (p = 0.005).
Within the LG 80% (n = 8) of patients required one night
in level II care. In the OG 100% of the patients spent one
night in level II care (p = 0.282), with one patient requir-
ing 4 nights of level II care. This patient was admitted as
an emergency with a liver abscess in the left lateral seg-
ment of the liver. The prolonged level II care stay was due
to multiple factors: poor post-operative analgesic control
(unilateral epidural block); ischaemic changes on ECG
(Troponin I negative) and a hypoxic episode day 2 post-
operatively. A subsequent CT pulmonary angiogram
revealed no pulmonary emboli.
The median postoperative in-hospital stay for the LG was
6 days (2-7) compared to 9 days (6-14) for the OG, show-
ing a highly significant difference, p = 0.005 (see Table 2).
Histology is shown in Table 3. 60% (n = 6) of lesions in
the LG and 40% (n = 4) in the open group were malig-
nant. The median total weight for the resected specimens
in the LG was 243.5 g (99 g-577 g) versus 439 g (213 g-
1480 g) in the OG (p = 0.023). Resection margins for all
malignant lesions were clear. In the LG the median resec-
tion margin was 15 mm (3-30 mm) with the median in
the OG 14.5 mm (< 1 mm ->20 mm)(p = 0.669).
The median follow-up in the LG was 18 months (0-63)
and 6 months (0-33) in the OG. Of the malignant cases,
post-LLS recurrence in the liver has occurred in 2/6 of the
LG (median 14 months) and in 2/4 of the OG (19 months
[10-28]). To date no port-site metastases have occurred in
these patients.
Table 3: Pathology
Patient no. Approach 
(laparoscopic/
open)
Pedicle clamping 
(yes/no)
Histology Size of lesions 
(cm)
Resection 
margin (mm)
Specimen weight 
(grams)
1 Laparoscopic No Simple cysts 0.17 with minute 
satellite cysts
n/a 325
2 Laparoscopic No FNH 7 × 6 × 6 Clear 150
3 Laparoscopic No FNH 7.5 × 7 × 5 Clear 452
4 Laparoscopic No Simple cysts Multiloculated 0.5-
14 diameter
N/a 175
5 Laparoscopic No Colorectal 
metastases
3.5 × 3.2 × 3.0 20 225
6 Laparoscopic No Colorectal 
metastases
3.2 × 1.5 × 2.0 10 269
7 Laparoscopic No Colorectal 
metastases
8 × 10 × 9 3 577
8 Laparoscopic No Colorectal 
metastases
No information 4 248
9 Laparoscopic No Colorectal 
metastases
1 × 1 × 0.4 30 239
10 Laparoscopic No Colorectal 
metastases
2.3 × 2.0 × 1.2 23 99
11 Open No Abscess 3.0 and 4.0 n/a 450
12 Open No Abscess 14 × 7 × 6 20 680
13 Open Yes Leiomyosarcoma 14 × 18 × 7 17 1480
14 Open No HCC 15 × 11 × 11 12 975
15 Open No FNH 1.2 × 1.5 × 1.8 16 350
16 Open Yes Hydatid cyst ~3.0 diameter 0 671
17 Open Yes FNH 9.8 at greatest 
diameter
04 2 8
18 Open No Colorectal 
metastases
8 × 6 × 4.5 > 20 213
19 Open Yes Abscess 5 × 5 × 3.5 3 278
20 Open Yes Colorectal 
metastases
1.7 at greatest 
diameter
02 6 5BMC Surgery 2009, 9:14 http://www.biomedcentral.com/1471-2482/9/14
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Discussion
This study echoes the growing body of evidence demon-
strating that a laparoscopic approach to liver surgery pro-
vides tangible benefits to both patient and hospital. As
surgical skill develops it is anticipated that left lateral seg-
mentectomy will shift from being a traditionally open
procedure to a laparoscopic one. This in turn may benefit
an increasing number of patients for whom open surgery
could be considered high risk.
The findings of this study are consistent with other pub-
lished series showing laparoscopic liver surgery to be fea-
sible and safe [2-5,12,20]. A 20% post-operative
morbidity rate (< 30 days) was comparable between the
open and laparoscopic group. There were no liver related
complications, chest or wound infections in either group.
Within the laparoscopic group, conversion to an open
procedure occurred in one patient (10%) to ensure nar-
rowing of the oesophago-gastric junction did not occur.
The need to convert to an open procedure has commonly
resulted from uncontrollable bleeding [12,13,18,20]. As
surgical techniques improve conversion rates have
decreased, with early experiences reporting a 33% conver-
sion rate [13] to Chang et al [20] reporting a 2.7% conver-
sion rate due to bleeding. In this series no operations were
converted to open due to bleeding.
During design of this study we excluded cases in both
groups which had undergone previous liver resections,
synchronous operations (liver resections, biliary proce-
dures, reversal of ileostomy, hernia repairs), polycystic
liver disease (inc. fenestration of liver cysts), liver cirrhosis
and hand-port assisted procedures. The main objectives of
this study were to compare operative time, analgesic
requirement and morbidity between the open and lapar-
oscopic approach. As such we felt it necessary to control
for these variables despite its impact on sample size. This
is a retrospective cohort study and as such we recognise
the slight disparity in heterogeneity of pathologies
included in the final analysis.
Portal clamping was not required in the LG. In the OG
50% (n = 5) of patients underwent clamping for a median
duration of 35 mins (11-60 mins). Early experiences in
the literature utilised portal clamping to a greater extent
with the laparoscopic versus the open approach[18], with
a resultant decrease in blood loss. In this series, the open
group maintained a low central venous pressure (CVP)
and utilised intermittent portal clamping resulting in
minimal need for blood transfusion (20% n = 2). Whilst
not requiring portal clamping, the laparoscopic technique
relied on the positive pressure of the pneumoperitoneum,
which in turn minimised potential blood loss, with only
one patient (10%) receiving a blood transfusion.
In laparoscopic liver surgery there are long standing con-
cerns regarding gas emboli [14] with laparoscopic sur-
geons opting for abdominal wall lifting (gasless
laparoscopy) or using low CO2 pressures to maintain
pneumoperitoneum, to minimise any potential risk. Ani-
mal studies have shown an increased risk of cardiac
arrhythmias [15] and gas emboli in those with 16 mmHg
compared to 8 mmHg (after the left hepatic vein was left
open for 3 minutes) [16]. Whilst this implies increased
pneumoperitoneal pressures may exacerbate the risk of
gas emboli, no human data exists. Potential advantages of
increased pneumoperitoneal pressure include reduction
in blood loss and improved visualisation of the operative
field. In this series pneumoperitoneal pressures were
maintained at 15-20 mmHg with no clinical adverse inci-
dents however, a prospective study in this field is overdue.
No significant difference was found in the operating time
between the two groups (220 vs 179 minutes, p = 0.315),
consistent with both Mala et al [21] and Mamada et al
[22]. Other groups have shown longer operating times in
the LG [18,23]. Of interest, in the LG and the OG the
shortest operating times were comparable (116 vs 118
minutes). It must be highlighted that the left lateral seg-
mentectomy is considered a training operation. As such,
surgeons in training (under the supervision of the Con-
sultant) operated on some of the open group (n = 4).
These data also includes the first laparoscopic LLS per-
formed by the laparoscopic surgeon therefore reflecting
the learning curve; the median laparoscopic operating
time in 2002 was 240 minutes and by 2006 it was 163
minutes. It is expected that laparoscopic operating time
for this procedure will continue to reduce however, these
factors may affect comparison of operative time.
One patient in the LG had an epidural (10%), while 90%
(n = 9) required an epidural in the OG (p = 0.003). It is
not routine for the laparoscopic liver patients to require
epidural anaesthesia but is protocol for open liver resec-
tions to have an epidural inserted preoperatively. In the
LG, port-site infiltration of local anaesthetic was used to
optimise post-operative analgesia however, port-site infil-
tration has been shown to have no impact on post-opera-
tive pain after analgesia [24]. To account for these
discrepancies, we assessed the total number of days post-
operative opiate analgesia was required, including all
methods of opiate administration. This revealed signifi-
cantly less opiate analgesia was required in the LG postop-
eratively (2 vs 5 days, p = 0.005). In their randomised
clinical trial Veldkamp et al [25] found there was a need
for fewer analgesics in the laparoscopic vs open group fol-
lowing surgery for colon cancer. This reduced demand for
post-operative analgesia was also found by Farges et al
[26] with 50% less morphine (15.5 mg vs 31.6 mg)BMC Surgery 2009, 9:14 http://www.biomedcentral.com/1471-2482/9/14
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administered in the laparoscopic versus open approach
following liver resection.
All patients in the OG and 80% of the LG were routinely
transferred to level II care with a median stay of one night.
With increased confidence and experience this policy has
since been modified. Currently patients from both groups
no longer routinely require level II care, and the more
stringent use of these resources has favourable cost impli-
cations for future service development.
In this study the median post-operative in-hospital stay
was significantly less in the LG than OG (6 vs 9 days, p =
0.005). In other comparative studies, laparoscopic versus
open liver resections for colorectal metastases the median
post-operative stay was 4 days vs 8.5 days (p < 0.001) [13],
and for hepatic resections 7.8 days vs 11.6 days (p < 0.05)
[23] and 10.4 vs 18.0 days (p < 0.05) [21]. This demon-
strates reduced post-operative in-patient stay is a repro-
ducible, safe benefit of laparoscopic liver resection.
The weights of the resected specimens in the LG were sig-
nificantly lower than the OG (p = 0.023). On histological
examination of the normal liver in the specimens there
was no difference with respect to clamping to account for
the weight disparity. Mala et al [21] also noted signifi-
cantly lighter specimens resected laparoscopically, along
with no significant difference in resection margin involve-
ment. This may reflect a slight difference in operative tech-
niques between the two approaches. The left hepatic vein
is approached and transection of the major vessels occurs
intra-hepatically in the laparoscopic group. We speculate
that this results in a rounded superior resection, account-
ing for this difference.
Oncological integrity is often questioned in laparoscopic
liver resections for malignancy. In this study resection
margins were clear in all malignant cases (median laparo-
scopic 15 mm vs open 14.5 mm). However, early experi-
ences of laparoscopic oncological surgery resulted in an
increased fear of developing abdominal wall metastases
after laparoscopy for hepatic cancer compared with open
surgery. Hypotheses suggested the peritoneum may be
damaged by the pneumoperitoneum, inducing intra-peri-
toneal tumour growth [11]. However this notion is
becoming outdated. A short-term animal study by Agnosti
et al [27] showed no significant difference in terms of
tumour growth, irrespective of gas or pneumoperitoneum
pressure used. Jacobi et al [28] suggest intra-peritoneal
tumour growth increases for pressures < 10 mmHg and
decreases at higher pressures. There is also further evi-
dence that reported tumour growth in colonic cancer was
significantly reduced after CO2 laparoscopy when com-
pared to gasless laparoscopy [29]. A meta-analysis of over
1 500 patients undergoing laparoscopic vs open colec-
tomy for colon cancer found no difference in the 3 year
survival rate (82.2% vs 83.3%) [30], concluding that a
laparoscopic approach is indeed oncologically safe.
Any potential risk of port-site metastases can be reduced
by maintaining an intact surgical specimen and using
plastic retrieval devices [20,31], thus minimising contact
with the extra-peritoneal structures.
There is evidence that the reduced stress response of lapar-
oscopic surgery may be preferential in the malignant cases
due to associated lower rates of infection and potential
reduction in tumour recurrence [32,33]. Animal data sug-
gests that increased surgical stress augments cancer metas-
tasis via surgical stress-induced expression of proteinases
in the target organ of metastasis [34]. There is also a
diminished stress response to the laparoscopic approach
versus open liver resection, preserving immune function
[32].
An additional benefit of the laparoscopic approach is
reduced adhesion formation [32] which may facilitate fur-
ther liver resections for metastases. With an increasing
trend for non-anatomical and segmental resections with
increased parenchymal preservation [35], repeat metastec-
tomies (and re-resections) are becoming more common.
Petrowsky et al [36] report similar outcomes for patients
having either a primary or repeat laparoscopic resection
following an initial resection performed laparoscopically.
These findings have led to an increased number of
patients undergoing further liver metastatectomy, present-
ing a further interventional option as multiple staged liver
resections become more commonplace.
Conclusion
The laparoscopic approach to left lateral segmentectomy
is safe and feasible with reproducible results. In a special-
ised unit, it may offer no difference in operating time,
morbidity and mortality rates and oncological clearance.
Potential benefits include reduced opiate analgesic
requirements and shorter hospital stay however, the
importance of patient selection cannot be over-empha-
sised.
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